THE IMPACT OF 68GA-PSMA PET/CT ON THERAPY MANAGEMENT OF HIGH RISK PROSTATE CANCER

THE IMPACT OF 68GA-PSMA PET/CT ON THERAPY MANAGEMENT OF HIGH RISK PROSTATE CANCER

Objective: We evaluated the impact of 68Ga-PSMA PET/CT (PSMA PET) on therapy management of newly diagnosed highrisk prostate cancer (PCa). Material and Method: Patients who underwent a PSMA PET for primary staging of high-risk PCa were evaluated retrospectively. Patients had abdominopelvic CT (n=126...

Full description

Saved in:

Bibliographic Details
Main Authors:	Duygu Has Şimşek, Emine Göknur Işık, Caner Civan, Zeynep Gözde Özkan, Serkan Kuyumcu, Ayça İribaş, Mehmet Öner Şanlı, Yasemin Şanlı
Format:	Article
Language:	English
Published:	Istanbul University Press 2021-01-01
Series:	İstanbul Tıp Fakültesi Dergisi
Subjects:	68ga-psma pet/ct prostate cancer staging therapy management
Online Access:	https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/D47CFD0796FA4E0BA1017BED1424C4E4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preliminary clinical study of p-iodo benzoyl moiety-modified PSMA inhibitors and prospective comparison with 68Ga-PSMA-11
by: Jianpeng Cao, et al.
Published: (2025-06-01)

Comparing the Diagnostic Performance of [18F]PSMA‐1007 With [68Ga]Ga‐PSMA‐11 in PET/CT Imaging and Staging of Recurrent Prostate Cancer
by: Negar Abdi, et al.
Published: (2025-03-01)

Unexpected discovery of hepatic cancer via 68Ga-PSMA PET/CT in the staging of prostate cancer
by: Radu Alexa, et al.
Published: (2025-06-01)

Imply on diagnosis and early prognosis of preoperative [68Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin
by: K. Pełka, et al.
Published: (2025-01-01)

An Innovative Approach with [<sup>68</sup>Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings
by: Gozde Mutevelizade, et al.
Published: (2025-07-01)

An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis
by: Paola Arena, et al.
Published: (2025-06-01)

Comparison of 18F-FDG and 68-PSMA-11 in PET for prostate cancer diagnosis
by: Natalia Fulle, et al.
Published: (2022-12-01)

Development and validation of a visual nomogram for predicting clinically significant prostate cancer in negative mpMRI using 68Ga-PSMA PET/CT
by: Wei Hu, et al.
Published: (2025-07-01)

Head-to-head comparison of 68Ga-PSMA-11 and 18F-FDG in delayed PET/CT imaging in prostate cancer diagnosis
by: Biyao Hu, et al.
Published: (2025-04-01)

A case of well-differentiated hepatocellular carcinoma identified on gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography
by: Hian Huang, et al.
Published: (2018-04-01)

Indications and Results for Ga-68 PSMA PET/CT in Patients with Biochemical Relapse of Prostate Cancer
by: Ivan Rogić, et al.
Published: (2024-01-01)

Cancers and Benign Processes on 68Ga PSMA PET-CT Imaging Other than Prostate Cancer
by: Pinar Pelin Ozcan, et al.
Published: (2022-06-01)

EVALUATION OF 68Ge/68Ga GENERATOR PRE-ELUTION EFFICIENCY ON METALLIC IMPURITIES IN THE COMPOSITION OF 68GaPSMA-11 RADIOPHARMACEUTICAL IN NUCLEAR MEDICINE PET CHEMISTRY
by: Ayşe Uğur, et al.
Published: (2021-09-01)

Investigating the significance of SPECT/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review
by: Tahani O. Alkahtani
Published: (2025-01-01)

Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform
by: Sebastian Martin, et al.
Published: (2024-12-01)

Deep learning (DL)‐based advancements in prostate cancer imaging: Artificial intelligence (AI)‐based segmentation of 68Ga‐PSMSA PET for tumor volume assessment
by: Sharjeel Usmani, et al.
Published: (2025-06-01)

<sup>68</sup>Ga Extemporaneous Preparations in Radiopharmacy
by: Marzia Rizzello, et al.
Published: (2025-06-01)

Preclinical Evaluation of a Novel PSMA-Targeted Agent <sup>68</sup>Ga-NOTA-GC-PSMA for Prostate Cancer Imaging
by: Wenjin Li, et al.
Published: (2025-03-01)

Optimization of radiochemical purity assessment for [68Ga]Ga-EDOTREOTIDE (Somakit-TOC®): a shortened r-TLC method for improved PET radiopharmaceutical workflow
by: Arnaud Deschavannes, et al.
Published: (2025-05-01)

Optimization of the Use of the DOTATATE Kit Manufactured by the Thailand Institute of Nuclear Technology Using a SiO2-based 68Ge/68Ga Generator
by: Phattarayut Jaiuea, et al.
Published: (2024-11-01)

Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents
by: Ute Hennrich, et al.
Published: (2025-06-01)

Staging Gallium-68 DOTATATE PET/CT Imaging in Neuroendocrine Tumors: Relationship between Measured SUVmax of the Primary Tumor and the Pathological Grade and Ki-67 Proliferation Index
by: Emin Büyüktalancı, et al.
Published: (2025-02-01)

EVALUATING LONG-TERM EXTERNAL DOSES AT SHORT RANGE IN PATIENTS RECEIVING 131I TREATMENT FOR DIFFERENTIATED THYROID CARCINOMA
by: Bilal Kovan, et al.
Published: (2024-07-01)

Sum-peak method with two NaI(Tl) crystals: 68(Ge+Ga) standardization
by: Estela Maria Oliveira, et al.
Published: (2019-10-01)

The tumour sink effect on 68Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study
by: Atefeh Zamanian, et al.
Published: (2025-07-01)

CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹⁸F-FDG AND ⁶⁸GA-PSMA PET/CT
by: Alexandre Mercuri Barbosa, et al.
Published: (2025-05-01)

Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma
by: Qingqing Pan, et al.
Published: (2025-06-01)

Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024-10-01)

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
by: Lucia Zanoni, et al.
Published: (2024-11-01)

Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis
by: O. E. Klementyeva, et al.
Published: (2020-08-01)

Evaluation of 68Ga-DOTA-Ubiquicidin (29–41) for imaging Staphylococcus aureus (Staph A) infection and turpentine-induced inflammation in a preclinical setting
by: Dilip Kumar Boddeti, et al.
Published: (2021-07-01)

[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism
by: Peter Kühnen, et al.
Published: (2025-08-01)

Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?
by: Çağlagül Erol, et al.
Published: (2022-08-01)

PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patient
by: Venetia A. Florou, et al.
Published: (2025-05-01)

Testing the diagnostic accuracy of a 68Ga-PSMA PET Scan in Early Biochemical Recurrence of Prostate Cancer
by: Vigna-Taglianti Riccardo, et al.
Published: (2024-10-01)

Spatial Resolution of a small animal PET scanner using 68Ga isotope
by: Victoria M. Garcia, et al.
Published: (2024-04-01)

PSMA5 as a modulator of glioblastoma senescence and prognosis
by: Jiahao Yao, et al.
Published: (2025-07-01)

Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI
by: Clemens P. Spielvogel, et al.
Published: (2024-12-01)

Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors
by: Sara Pellegrino, et al.
Published: (2025-05-01)

Juvenile Idiopathic Arthritis Subtype- and Sex-specific Associations with Genetic Variants in the PSMA6/PSMC6/PSMA3 Gene Cluster
by: Tatjana Sjakste, et al.
Published: (2014-10-01)